|
Q4 FY2019
As of Dec 31, 2019
|
Q3 FY2019
As of Sep 30, 2019
|
Q2 FY2019
As of Jun 30, 2019
|
Q1 FY2019
As of Mar 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
Q3 FY2018
As of Sep 30, 2018
|
Q2 FY2018
As of Jun 30, 2018
|
Q1 FY2018
As of Mar 31, 2018
|
Q4 FY2017
As of Dec 31, 2017
|
Q3 FY2017
As of Sep 30, 2017
|
Q2 FY2017
As of Jun 30, 2017
|
Q1 FY2017
As of Mar 31, 2017
|
Q4 FY2016
As of Dec 31, 2016
|
Q3 FY2016
As of Sep 30, 2016
|
Q2 FY2016
As of Jun 30, 2016
|
Q1 FY2016
As of Mar 31, 2016
|
Q4 FY2015
As of Dec 31, 2015
|
Q3 FY2015
As of Sep 30, 2015
|
Q2 FY2015
As of Jun 30, 2015
|
Q1 FY2015
As of Mar 31, 2015
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents (Note 8) | ||||||||||||||||||||
| Restricted cash (Note 6) | ||||||||||||||||||||
| Restricted cash (Note 8) | ||||||||||||||||||||
| Counterparty collateral (Note 8) | ||||||||||||||||||||
| Trade receivables (Note 8) | ||||||||||||||||||||
| Related party receivable | ||||||||||||||||||||
| Derivative assets, current (Note 8) | ||||||||||||||||||||
| Prepaid expenses (Note 8) | ||||||||||||||||||||
| Deferred financing costs, current, net of accumulated amortization of $2,111 and $2,580 as of March 31, 2018 and December 31, 2017, respectively | ||||||||||||||||||||
| Deferred financing costs, current, net of accumulated amortization of $6 and $3 as of December 31, 2019 and December 31, 2018, respectively | ||||||||||||||||||||
| Assets held for sale | ||||||||||||||||||||
| Sales tax receivable | ||||||||||||||||||||
| Notes receivable, current (Note 8) | ||||||||||||||||||||
| Other current assets (Note 8) | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Restricted cash (Note 6) | ||||||||||||||||||||
| Restricted cash (Note 8) | ||||||||||||||||||||
| Major construction advances (Note 8) | ||||||||||||||||||||
| Construction in progress (Note 8) | ||||||||||||||||||||
| Property, plant and equipment, net (Note 8) | ||||||||||||||||||||
| Unconsolidated investments (Note 8) | ||||||||||||||||||||
| Derivative assets | ||||||||||||||||||||
| Deferred financing costs | ||||||||||||||||||||
| Deferred financing costs (Note 8) | ||||||||||||||||||||
| Net deferred tax assets | ||||||||||||||||||||
| Intangible assets, net (Note 8) | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Notes receivable (Note 8) | ||||||||||||||||||||
| Other assets (Note 8) | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities, mezzanine equity and equity | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable and other accrued liabilities (Note 8) | ||||||||||||||||||||
| Accrued construction costs (Note 8) | ||||||||||||||||||||
| Counterparty collateral liability (Note 8) | ||||||||||||||||||||
| Accrued interest (Note 8) | ||||||||||||||||||||
| Dividends payable | ||||||||||||||||||||
| Derivative liabilities, current (Note 8) | ||||||||||||||||||||
| Revolving credit facility, current | ||||||||||||||||||||
| Current portion of long-term debt, net | ||||||||||||||||||||
| Liabilities related to assets held for sale | ||||||||||||||||||||
| Current portion of long-term debt, net (Note 8) | ||||||||||||||||||||
| Contingent liabilities, current | ||||||||||||||||||||
| Asset retirement obligations, current (Note 8) | ||||||||||||||||||||
| Other current liabilities (Note 8) | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Revolving credit facility | ||||||||||||||||||||
| Long-term debt, net | ||||||||||||||||||||
| Convertible senior notes, net of financing costs of $4,172 and $5,014 as of September 30, 2016 and December 31, 2015, respectively | ||||||||||||||||||||
| Long-term debt, net (Note 8) | ||||||||||||||||||||
| Derivative liabilities (Note 8) | ||||||||||||||||||||
| Asset retirement obligations | ||||||||||||||||||||
| Net deferred tax liabilities | ||||||||||||||||||||
| Intangible liabilities, net | ||||||||||||||||||||
| Contingent liabilities (Note 8) | ||||||||||||||||||||
| Contingent liabilities | ||||||||||||||||||||
| Asset retirement obligations (Note 8) | ||||||||||||||||||||
| Other long-term liabilities (Note 8) | ||||||||||||||||||||
| Contract liability | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Series A Preferred Stock, $0.01 par value per share; 100,000,000 preferred shares authorized; 10,400,000 and 0 shares of Series A Preferred Stock outstanding as of December 31, 2019 and December 31, 2018, respectively | ||||||||||||||||||||
| Equity: | ||||||||||||||||||||
| Class A common stock, $0.01 par value per share; 500,000,000 shares authorized; 98,199,909 and 98,051,629 shares outstanding as of December 31, 2019 and December 31, 2018, respectively | ||||||||||||||||||||
| Total class A common stock, $0.01 par value per share; 500,000,000 shares authorized; 98,199,909 and 98,051,629 shares outstanding as of December 31, 2019 and December 31, 2018, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated loss | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Treasury stock, at cost; 289,690 and 223,040 shares of Class A common stock as of December 31, 2019 and December 31, 2018, respectively | ||||||||||||||||||||
| Total treasury stock, at cost; 289,690 and 223,040 shares of Class A common stock as of December 31, 2019 and December 31, 2018, respectively | ||||||||||||||||||||
| Total equity before noncontrolling interests | ||||||||||||||||||||
| Noncontrolling interests | ||||||||||||||||||||
| Total equity | ||||||||||||||||||||
| Total liabilities, mezzanine equity and equity | ||||||||||||||||||||
Loading...
